Meropenem Injection, Powder, For Solution
Product Images NDC 25021-160

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 25021-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mer0f 0000 01)

Chemical structure diagram of the active ingredient Meropenem, depicting its molecular arrangement including a beta-lactam ring, carboxylic acid group, and dimethylcarbamoyl moiety, with three associated water molecules (3H2O).*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 02)

Meropenem for Injection, USP 500 mg per vial (meropenem equivalent) injection powder label. The single-dose vial is for intravenous use only. Label includes dosage details, storage instructions, and manufacturer information for Sagent Pharmaceuticals.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 03)

Label for Meropenem for Injection, USP 1 gram per vial powder for solution. The label states the product is for intravenous use only, single-dose vial, and contains 1 gram of meropenem equivalent. It is manufactured by Sagent Pharmaceuticals and includes storage and administration instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.